NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.1223
+0.0104 (9.29%)
Apr 23, 2025, 1:47 PM EDT

NKGen Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21
Market Capitalization
660--
Enterprise Value
3671--
Last Close Price
0.122.759.959.69
PB Ratio
-0.12-1.03--
Debt / Equity Ratio
-0.65-0.347.70-1.37
Asset Turnover
--0.00-
Quick Ratio
0.000.000.010.01
Current Ratio
0.030.050.020.01
Return on Assets (ROA)
-97.34%-113.32%-88.47%-
Return on Capital (ROIC)
---110.60%-
Earnings Yield
-880.44%-137.81%--
FCF Yield
--36.46%--
Buyback Yield / Dilution
-103.97%-142.70%55.40%-
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.